NANO-X IMAGING LTD (NNOX) Stock Fundamental Analysis

NASDAQ:NNOX • IL0011681371

2.34 USD
+0.04 (+1.74%)
At close: Feb 18, 2026
2.34 USD
0 (0%)
Pre-Market: 2/19/2026, 4:50:05 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

NNOX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for NNOX as it has an excellent financial health rating, but there are worries on the profitability. NNOX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NNOX has reported negative net income.
  • NNOX had a negative operating cash flow in the past year.
  • NNOX had negative earnings in each of the past 5 years.
  • NNOX had a negative operating cash flow in each of the past 5 years.
NNOX Yearly Net Income VS EBIT VS OCF VS FCFNNOX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

  • The Return On Assets of NNOX (-31.64%) is worse than 85.29% of its industry peers.
  • NNOX has a Return On Equity of -35.55%. This is in the lower half of the industry: NNOX underperforms 70.59% of its industry peers.
Industry RankSector Rank
ROA -31.64%
ROE -35.55%
ROIC N/A
ROA(3y)-32.63%
ROA(5y)-26.69%
ROE(3y)-37.21%
ROE(5y)-30.36%
ROIC(3y)N/A
ROIC(5y)N/A
NNOX Yearly ROA, ROE, ROICNNOX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NNOX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NNOX Yearly Profit, Operating, Gross MarginsNNOX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • NNOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NNOX has more shares outstanding
  • Compared to 5 years ago, NNOX has more shares outstanding
  • Compared to 1 year ago, NNOX has an improved debt to assets ratio.
NNOX Yearly Shares OutstandingNNOX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
NNOX Yearly Total Debt VS Total AssetsNNOX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • NNOX has an Altman-Z score of 0.96. This is a bad value and indicates that NNOX is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of NNOX (0.96) is worse than 68.63% of its industry peers.
  • NNOX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.96
ROIC/WACCN/A
WACC8.62%
NNOX Yearly LT Debt VS Equity VS FCFNNOX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • NNOX has a Current Ratio of 4.14. This indicates that NNOX is financially healthy and has no problem in meeting its short term obligations.
  • NNOX has a better Current ratio (4.14) than 91.18% of its industry peers.
  • NNOX has a Quick Ratio of 3.93. This indicates that NNOX is financially healthy and has no problem in meeting its short term obligations.
  • NNOX has a Quick ratio of 3.93. This is amongst the best in the industry. NNOX outperforms 90.20% of its industry peers.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 3.93
NNOX Yearly Current Assets VS Current LiabilitesNNOX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. Growth

3.1 Past

  • NNOX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.29%.
  • NNOX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.19%.
  • Measured over the past years, NNOX shows a very strong growth in Revenue. The Revenue has been growing by 105.51% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)15.19%
Revenue growth 3Y105.51%
Revenue growth 5YN/A
Sales Q2Q%13.72%

3.2 Future

  • The Earnings Per Share is expected to grow by 25.40% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 77.13% on average over the next years. This is a very strong growth
EPS Next Y-4.8%
EPS Next 2Y16.73%
EPS Next 3Y17.84%
EPS Next 5Y25.4%
Revenue Next Year11.87%
Revenue Next 2Y63.07%
Revenue Next 3Y68.88%
Revenue Next 5Y77.13%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
NNOX Yearly Revenue VS EstimatesNNOX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
NNOX Yearly EPS VS EstimatesNNOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • NNOX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year NNOX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NNOX Price Earnings VS Forward Price EarningsNNOX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNOX Per share dataNNOX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NNOX's earnings are expected to grow with 17.84% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.73%
EPS Next 3Y17.84%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NNOX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NANO-X IMAGING LTD

NASDAQ:NNOX (2/18/2026, 8:00:01 PM)

Premarket: 2.34 0 (0%)

2.34

+0.04 (+1.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-20
Earnings (Next)03-30
Inst Owners19.55%
Inst Owner Change3.07%
Ins Owners0.22%
Ins Owner Change16.81%
Market Cap161.95M
Revenue(TTM)12.30M
Net Income(TTM)-55.71M
Analysts84
Price Target8.31 (255.13%)
Short Float %12.66%
Short Ratio6.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.59%
Min EPS beat(2)-18.68%
Max EPS beat(2)3.49%
EPS beat(4)2
Avg EPS beat(4)-5.4%
Min EPS beat(4)-18.68%
Max EPS beat(4)3.49%
EPS beat(8)5
Avg EPS beat(8)8.63%
EPS beat(12)6
Avg EPS beat(12)-1.82%
EPS beat(16)7
Avg EPS beat(16)-8.44%
Revenue beat(2)0
Avg Revenue beat(2)-5.27%
Min Revenue beat(2)-7.01%
Max Revenue beat(2)-3.53%
Revenue beat(4)0
Avg Revenue beat(4)-15.94%
Min Revenue beat(4)-30.68%
Max Revenue beat(4)-3.53%
Revenue beat(8)0
Avg Revenue beat(8)-21.55%
Revenue beat(12)0
Avg Revenue beat(12)-21.38%
Revenue beat(16)1
Avg Revenue beat(16)-14.7%
PT rev (1m)0%
PT rev (3m)5.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.5%
EPS NY rev (1m)0%
EPS NY rev (3m)4.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 13.16
P/FCF N/A
P/OCF N/A
P/B 1.03
P/tB 1.71
EV/EBITDA N/A
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.18
BVpS2.26
TBVpS1.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.64%
ROE -35.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-32.63%
ROA(5y)-26.69%
ROE(3y)-37.21%
ROE(5y)-30.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 36.96%
Cap/Sales 35.41%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 3.93
Altman-Z 0.96
F-Score3
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)37.93%
Cap/Depr(5y)1552.65%
Cap/Sales(3y)47.15%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y-4.8%
EPS Next 2Y16.73%
EPS Next 3Y17.84%
EPS Next 5Y25.4%
Revenue 1Y (TTM)15.19%
Revenue growth 3Y105.51%
Revenue growth 5YN/A
Sales Q2Q%13.72%
Revenue Next Year11.87%
Revenue Next 2Y63.07%
Revenue Next 3Y68.88%
Revenue Next 5Y77.13%
EBIT growth 1Y-6.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.37%
OCF growth 3YN/A
OCF growth 5YN/A

NANO-X IMAGING LTD / NNOX FAQ

Can you provide the ChartMill fundamental rating for NANO-X IMAGING LTD?

ChartMill assigns a fundamental rating of 3 / 10 to NNOX.


What is the valuation status for NNOX stock?

ChartMill assigns a valuation rating of 0 / 10 to NANO-X IMAGING LTD (NNOX). This can be considered as Overvalued.


How profitable is NANO-X IMAGING LTD (NNOX) stock?

NANO-X IMAGING LTD (NNOX) has a profitability rating of 0 / 10.


What is the earnings growth outlook for NANO-X IMAGING LTD?

The Earnings per Share (EPS) of NANO-X IMAGING LTD (NNOX) is expected to decline by -4.8% in the next year.